Alicia Rizo Gellida

Influence of body mass index on disease severity and treatment outcomes in primary aldosteronism

Marta Araujo Castro, Jessica Goi, Jacopo Burrello, Silvia Monticone et autres

Abstract Purpose To assess the impact of body mass index (BMI) on disease severity, cardiac remodeling, and clinical and biochemical outcomes after surgical and medical treatment in patients with primary aldosteronism (PA). Methods This international retrospective study included patients diagnosed with PA …

es, by, it, de, us (code pays fourni par la source)

Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registry

Jessica Goi, Miguel Paja Fano, Alicia Rizo Gellida, Marga González-Boillos et autres

BACKGROUND: Data on factors predicting favorable response to medical therapy in primary aldosteronism, based on Primary Aldosteronism Medical treatment Outcome (PAMO) criteria, remain limited. AIM: This study aimed to identify baseline parameters independently associated with clinical and biochemical responses to mineralocorticoid receptor …

es (code pays fourni par la source)

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism

Jessica Goi, Alicia Rizo Gellida, Marga González-Boillos, Patricia Martín Rojas‐Marcos et autres

CONTEXT: Perioperative use of mineralocorticoid receptor antagonists (MRA) in patients with unilateral primary aldosteronism (PA) awaiting surgery is not well standardized. OBJECTIVE: The aim of this study was to compare the risk of postoperative complications and surgical outcomes between PA patients treated …

es (code pays fourni par la source)

Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain

Jessica Goi, Alicia Rizo Gellida, Marga González-Boillos, Patricia Martín Rojas‐Marcos et autres

OBJECTIVE: This study aims to analyze current medical management of primary aldosteronism (PA) in Spain, including doses, adverse events (AEs), and efficacy. METHODS: SPAIN-ALDO is a national, multicenter, retrospective registry of patients with PA in Spain. For this study, information about medical …

es, us (code pays fourni par la source)

Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO

María Bernarda Iriarte-Durán, Miguel Paja, Alicia Rizo Gellida, Marga González-Boillos et autres

co, es (code pays fourni par la source)